Predictive Health Intelligence has released hepatoSIGHT, a data-driven tool that identifies people with undiagnosed liver disease, using historic blood tests.
Marko Aliaksandr Shutterstock
2023469570
liver
Pilot studies in Somerset NHS Foundation Trust have demonstrated that hepatoSIGHT can quickly and easily find people at risk of developing advanced liver disease, allowing them to be treated far earlier.
Prof. Daniel Meron, DM FRCPsych MBA, chief medical officer Somerset NHS FT & Yeovil District Hospital NHS Foundation Trust, said: “This is a very exciting opportunity to change the way that healthcare is delivered. By finding people earlier in their disease pathway we are making a huge difference to their lives and the NHS. At a time of intense pressure such as this, using technology that empowers clinicians to get ahead is critical. At Somerset Foundation Trust we're proud to be leading the field alongside our partners at Predictive Health Intelligence.”
hepatoSIGHT was developed in partnership with public and patients with the needs of the NHS in mind and is designed to help doctors proactively find people with liver disease before it progresses. It is customisable to go beyond liver disease making it a solution allowing Integrated Care Boards to deliver a tailored approach to population health interventions.
Neil Stevens, managing director, Predictive Health Intelligence, said: "Following a comprehensive research and development programme in Somerset we're excited to introduce hepatoSIGHT to the market. Our team has worked hard to create a product, in conjunction with our technology partner Stalis, that is not only easy to use but also addresses the specific needs of the NHS. We are confident it will have a significant impact on the health of the nation, and we look forward to its adoption."
One patient who took part in the early project said: “I love this project as it is proactive and finds people who might not be ill now but can have some help and to make sure they don’t become ill in the future.”
